Monday, October 1, 2012
Four biotechs completed IPOs in 3Q12, raising $183 million.
In 3Q11, three companies raised $213.6 million. Thirteen biotechs have raised
$776.4 million via IPOs so far in 2012, compared with 14 that raised $727.7
million in the first nine months of 2011. The 2012 IPOs are up a median of 10%,